Data / Drug companies / Succinylcholine chloride
Succinylcholine chloride: 27 companies and 37 products in the FDA NDC directory
Succinylcholine chloride is listed in the FDA National Drug Code Directory by 27 companies, with 37 products in commercial distribution. 33 of the products (89.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on July 29, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 37
- Generic (ANDA) products
- 33 (89.2%)
- Application numbers
- 22
- Routes
- Intramuscular, Intravenous, Parenteral
- Brand names
- Anectine, Quelicin
- openFDA record search
- api.fda.gov
Companies that list succinylcholine chloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Medical Purchasing Solutions, LLC | 6 | injection, solution; injection | Generic drugs (ANDA) | November 3, 2020 |
| Baxter Healthcare Corporation | 2 | injection, solution | Generic drugs (ANDA) | September 24, 2024 |
| Fresenius Kabi USA, LLC | 2 | injection, solution | Generic drugs (ANDA) | June 19, 2025 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, solution | Generic drugs (ANDA) | October 19, 2021 |
| Sandoz Inc | 2 | injection, solution | New drug applications (NDA) | June 12, 2019 |
| Somerset Therapeutics, LLC | 2 | injection, solution | Generic drugs (ANDA) | May 30, 2023 |
| Be Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | February 7, 2022 |
| Camber Pharmaceuticals, Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 4, 2020 |
| Civica, Inc. | 1 | injection, solution | New drug applications (NDA) | December 11, 2020 |
| Devatis, Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 15, 2024 |
| Eugia US LLC | 1 | injection, solution | Generic drugs (ANDA) | October 16, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | January 25, 2021 |
| Gland Pharma Limited | 1 | injection, solution | Generic drugs (ANDA) | June 16, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | Generic drugs (ANDA) | January 21, 2021 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | July 22, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | April 26, 2021 |
| Hospira, Inc. | 1 | injection, solution | New drug applications (NDA) | April 30, 2005 |
| Indoco Remedies Limited | 1 | injection | Generic drugs (ANDA) | December 31, 2019 |
| Lifestar Pharma LLC | 1 | injection, solution | Generic drugs (ANDA) | February 2, 2023 |
| Micro Labs Limited | 1 | injection | Generic drugs (ANDA) | March 1, 2021 |
| Nordic Pharma, Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 20, 2024 |
| Piramal Critical Care Inc | 1 | injection, solution | Generic drugs (ANDA) | January 20, 2021 |
| ProPharma Distribution | 1 | injection, solution | Generic drugs (ANDA) | January 15, 2020 |
| Remedyrepack Inc. | 1 | injection, solution | Generic drugs (ANDA) | July 29, 2025 |
| Steriscience Specialties Private Limited | 1 | injection, solution | Generic drugs (ANDA) | September 30, 2024 |
| Zydus Lifesciences Limited | 1 | injection, solution | Generic drugs (ANDA) | May 10, 2018 |
| Zydus Pharmaceuticals USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 10, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 33 | 89.2% |
| Injection | 4 | 10.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 89.2% |
| New drug applications (NDA) | 4 | 10.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Depolarizing Neuromuscular Blocker | 37 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.